These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 24213150

  • 1. Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children.
    Jeong DC, Chung NG, Cho B, Zou Y, Ruan M, Takahashi Y, Muramatsu H, Ohara A, Kosaka Y, Yang W, Kim HK, Zhu X, Kojima S.
    Haematologica; 2014 Apr; 99(4):664-71. PubMed ID: 24213150
    [Abstract] [Full Text] [Related]

  • 2. Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study.
    Atta EH, Dias DS, Marra VL, de Azevedo AM.
    Ann Hematol; 2010 Sep; 89(9):851-9. PubMed ID: 20373101
    [Abstract] [Full Text] [Related]

  • 3. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
    Shin SH, Yoon JH, Yahng SA, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Kim HJ, Cho SG, Kim DW, Min WS, Park CW, Lee JW.
    Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia.
    Hayakawa J, Kanda J, Akahoshi Y, Harada N, Kameda K, Ugai T, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura SI, Kikuchi M, Yamazaki R, Kako S, Kanda Y.
    Int J Hematol; 2017 May; 105(5):578-586. PubMed ID: 28078653
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia.
    Atta EH, Lima CBL, Dias DSP, Clé DV, Bonduel MM, Sciuccati GB, Medeiros LA, Oliveira MM, Salvino MA, Garanito MP, Blum Fonseca PB, Saad STO, Calado RT, Scheinberg P.
    Ann Hematol; 2017 Nov; 96(11):1907-1914. PubMed ID: 28815305
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia.
    Afable MG, Shaik M, Sugimoto Y, Elson P, Clemente M, Makishima H, Sekeres MA, Lichtin A, Advani A, Kalaycio M, Tiu RV, O'Keefe CL, Maciejewski JP.
    Haematologica; 2011 Sep; 96(9):1269-75. PubMed ID: 21606164
    [Abstract] [Full Text] [Related]

  • 9. Long-term outcomes of 172 children with severe aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine.
    Lan Y, Chang L, Yi M, Cai Y, Feng J, Ren Y, Liu C, Chen X, Wang S, Guo Y, Zhang A, Liu L, Zhang J, Zhu X.
    Ann Hematol; 2021 Jan; 100(1):53-61. PubMed ID: 33033910
    [Abstract] [Full Text] [Related]

  • 10. Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia.
    Kekre N, Zhang Y, Zhang MJ, Carreras J, Ahmed P, Anderlini P, Atta EH, Ayas M, Boelens JJ, Bonfim C, Deeg HJ, Kapoor N, Lee JW, Nakamura R, Pulsipher MA, Eapen M, Antin JH.
    Haematologica; 2017 Jul; 102(7):1291-1298. PubMed ID: 28341733
    [Abstract] [Full Text] [Related]

  • 11. Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood.
    Yoshimi A, van den Heuvel-Eibrink MM, Baumann I, Schwarz S, Simonitsch-Klupp I, de Paepe P, Campr V, Kerndrup GB, O'Sullivan M, Devito R, Leguit R, Hernandez M, Dworzak M, de Moerloose B, Stary J, Hasle H, Smith OP, Zecca M, Catala A, Schmugge M, Locatelli F, Führer M, Fischer A, Guderle A, Nöllke P, Strahm B, Niemeyer CM.
    Haematologica; 2014 Apr; 99(4):656-63. PubMed ID: 24162791
    [Abstract] [Full Text] [Related]

  • 12. Rabbit antithymocyte globulin treatment in childhood acquired severe aplastic anemia.
    Karapinar DY, Karadaş N, Ay Y, Akin M, Balkan C, Aydinok Y, Kavakli K.
    Pediatr Hematol Oncol; 2014 Feb; 31(1):20-8. PubMed ID: 23627541
    [Abstract] [Full Text] [Related]

  • 13. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia.
    Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Biancotto A, Wu CO, Young NS.
    N Engl J Med; 2011 Aug 04; 365(5):430-8. PubMed ID: 21812672
    [Abstract] [Full Text] [Related]

  • 14. In vivo effects of horse and rabbit antithymocyte globulin in patients with severe aplastic anemia.
    Feng X, Scheinberg P, Biancotto A, Rios O, Donaldson S, Wu C, Zheng H, Sato K, Townsley DM, McCoy JP, Young NS.
    Haematologica; 2014 Sep 04; 99(9):1433-40. PubMed ID: 24907357
    [Abstract] [Full Text] [Related]

  • 15. Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party.
    Marsh JC, Bacigalupo A, Schrezenmeier H, Tichelli A, Risitano AM, Passweg JR, Killick SB, Warren AJ, Foukaneli T, Aljurf M, Al-Zahrani HA, Höchsmann B, Schafhausen P, Roth A, Franzke A, Brummendorf TH, Dufour C, Oneto R, Sedgwick P, Barrois A, Kordasti S, Elebute MO, Mufti GJ, Socie G, European Blood and Marrow Transplant Group Severe Aplastic Anaemia Working Party.
    Blood; 2012 Jun 07; 119(23):5391-6. PubMed ID: 22544699
    [Abstract] [Full Text] [Related]

  • 16. Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group.
    Kamio T, Ito E, Ohara A, Kosaka Y, Tsuchida M, Yagasaki H, Mugishima H, Yabe H, Morimoto A, Ohga S, Muramatsu H, Hama A, Kaneko T, Nagasawa M, Kikuta A, Osugi Y, Bessho F, Nakahata T, Tsukimoto I, Kojima S, Japan Childhood Aplastic Anemia Study Group.
    Haematologica; 2011 Jun 07; 96(6):814-9. PubMed ID: 21422115
    [Abstract] [Full Text] [Related]

  • 17. Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study.
    Clé DV, Atta EH, Dias DSP, Lima CBL, Bonduel M, Sciuccati G, Medeiros LA, de Oliveira MM, Blum Fonseca PB, Saad STO, Hamerschlak N, Salvino MA, Garanito MP, Pazin-Filho A, Scheinberg P, Calado RT.
    Ann Hematol; 2018 Nov 07; 97(11):2039-2046. PubMed ID: 29978284
    [Abstract] [Full Text] [Related]

  • 18. Long-term outcomes of 95 children with moderate aplastic anemia treated with horse antithymocyte globulin and cyclosporine.
    Nishikawa E, Yagasaki H, Hama A, Yabe H, Ohara A, Kosaka Y, Kudo K, Kobayashi R, Ohga S, Morimoto A, Watanabe KI, Yoshida N, Muramatsu H, Takahashi Y, Kojima S.
    Pediatr Blood Cancer; 2017 May 07; 64(5):. PubMed ID: 27808465
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
    Zhu X, Guan J, Xu J, Wei J, Jiang L, Yin J, Zhao L, Zhang Y.
    Blood Cells Mol Dis; 2014 Sep 07; 53(3):157-60. PubMed ID: 24931461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.